ArticleCancer causes & control : CCC2026
Global trends in the burden of non-Hodgkin Lymphoma: a comprehensive analysis from 1990 to 2045.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeTo analyze global trends in the non-Hodgkin lymphoma (NHL) burden from 1990 to 2021 and forecast future trajectories from 2022 to 2045.
methodsUsing data from the GBD 2021 Study, we extracted age-standardized incidence, mortality, and disability-adjusted life year (DALY) rates and estimated their average annual percent changes (AAPCs). Age-period-cohort models were constructed to assess temporal trends, and decomposition analysis identified drivers of burden changes. Future projections were generated using the Nordpred model.
resultsFrom 1990 to 2021, the global incidence of NHL increased (AAPC = 0.53; 95% CI: 0.50-0.56), whereas mortality (AAPC = - 0.41) and DALY rates (AAPC = - -0.60) decreased. Aging accounted for 35% of incident cases, population growth accounted for 49%, and epidemiological changes accounted for - 14%. By 2045, projected cases, and deaths are expected to reach 985,820 and 437,933 respectively.
conclusionThe global burden of NHL continues to increase in terms of incident cases, whereas mortality and DALY rates show declining trends. Aging and population growth are the primary drivers. By 2045, NHL will still be a substantial public health challenge. High SDI regions should address workforce shortages and treatment costs, while low SDI regions need investments in early detection and infection control programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.